Pediatric neuro-AIDS may be the first clinical manifestation of HIV in
fection in children born to HN-infected mothers. As part of the neurod
evelopmental examination of children, the Clinical Adaptive Test/Clini
cal Linguistic and Auditory Milestone Scale (CAT/CLAMS) was investigat
ed as a tool for pediatricians to use to monitor the development of ch
ildren at risk for HIV infection. The CAT/CLAMS tvas found to detect n
eurodevelopmental differences between HIV-infected and uninfected chil
dren at 12 and 18 months of age. Good correlations were found between
the CAT/CLAMS and concurrently administered Bayley Scales of Infant De
velopment. These findings suggest that the CAT/CLAMS should be conside
red as a part of the neurodevelopmental examination of children at ris
k for pediatric neuro-AIDS.